Cargando…
Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007,...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826634/ https://www.ncbi.nlm.nih.gov/pubmed/20425209 http://dx.doi.org/10.1007/s11916-009-0092-z |
_version_ | 1782177871747350528 |
---|---|
author | Lawson, Erin F. Wallace, Mark S. |
author_facet | Lawson, Erin F. Wallace, Mark S. |
author_sort | Lawson, Erin F. |
collection | PubMed |
description | Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007, The Polyanalgesic Consensus Conference of expert panelists updated its algorithm for drug selection in IT polyanalgesia. We review this algorithm and the emerging therapy included. This article provides an update on newly approved as well as emerging IT agents and the advances in technology for their delivery. |
format | Text |
id | pubmed-2826634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-28266342010-03-05 Current Developments in Intraspinal Agents for Cancer and Noncancer Pain Lawson, Erin F. Wallace, Mark S. Curr Pain Headache Rep Article Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007, The Polyanalgesic Consensus Conference of expert panelists updated its algorithm for drug selection in IT polyanalgesia. We review this algorithm and the emerging therapy included. This article provides an update on newly approved as well as emerging IT agents and the advances in technology for their delivery. Current Science Inc. 2010-01-16 2010 /pmc/articles/PMC2826634/ /pubmed/20425209 http://dx.doi.org/10.1007/s11916-009-0092-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Lawson, Erin F. Wallace, Mark S. Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title | Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title_full | Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title_fullStr | Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title_full_unstemmed | Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title_short | Current Developments in Intraspinal Agents for Cancer and Noncancer Pain |
title_sort | current developments in intraspinal agents for cancer and noncancer pain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826634/ https://www.ncbi.nlm.nih.gov/pubmed/20425209 http://dx.doi.org/10.1007/s11916-009-0092-z |
work_keys_str_mv | AT lawsonerinf currentdevelopmentsinintraspinalagentsforcancerandnoncancerpain AT wallacemarks currentdevelopmentsinintraspinalagentsforcancerandnoncancerpain |